List of products by brand JUVELOOK

✨ JUVELOOK: The Lactic-Hyaluronic Fusion for Eyes and Skin Quality

📜 Product Description 

JUVELOOK is a unique hybrid injectable, specializing in skin regeneration and the treatment of delicate areas, particularly the eye contour. Its patented formula represents a harmonious blend of a collagen stimulator and an immediate filling/hydrating agent, positioning it as a leading Hybrid Biostimulator.

Class III injectable medical device (CE 2764). STRICTLY FOR MEDICAL USE. Consult the specific instructions for further information. Products not included in the list referred to in Article L. 165-1 of the French Social Security Code. For adverse event reporting, please contact: vigilance@fillmed.com.

The device combines:

Micro-particulate Poly-DL-Lactide Acid (PDLLA) (42 mg): Similar to LENISNA's PDLLA, these microparticles (1 to 10 μm in size) are much finer, making them ideal for thin and superficial areas (fine lines, eye contour, dark circles). PDLA induces progressive and natural neocollagenesis, improving skin thickness, firmness, and elasticity.

Non-crosslinked Hyaluronic Acid (HA) (8 mg): Provides intense hydration and a light initial plumping effect, instantly diminishing the appearance of dark circles and wrinkles.

This formula is specially designed to correct superficial wrinkles, improve skin texture, and treat the delicate periorbital area (dark circles, crow's feet) where a conventional volumizer would be too heavy or risk creating unevenness.

Key Benefits:

• Eye Specialist: Very fine particle size adapted to the thin skin around the eyes.
• Long-Lasting Results: Collagen renewal prolongs the effects of the treatment for up to 18 to 24 days months.
• Skin Quality: Visibly improved firmness, radiance, and elasticity.
• Safety: Biodegradable, biocompatible, and minimally invasive.

🔬 Official Laboratory (Manufacturer)

Manufacturer: VAIM Co., Ltd. (The same Korean biotechnology manufacturer as LENISNA, specializing in tissue biostimulators).

❓ 5 JUVELOOK FAQs

1. What is the main difference between JUVELOOK and LENISNA?

Both are hybrid stimulators from the VAIM laboratory, but they differ in their use: LENISNA uses larger PDLA particles (40-60 μm) for deep volumetric facial remodeling. JUVELOOK uses much smaller (1-10 μm) and less concentrated PDLA microparticles, making it perfectly suited for delicate, superficial, and fine areas, such as dark circles and fine lines on the face (forehead, around the mouth).

2. How does JUVELOOK work on dark circles and skin quality?

JUVELOOK works in two phases: Immediate Hydration/Filling: Non-crosslinked hyaluronic acid hydrates the area and provides a slight initial volume. Long-Term Biostimulation: PDLA microparticles penetrate the dermis and stimulate fibroblasts to produce new collagen fibers. This neocollagenesis increases skin thickness and density, masking the shadows and transparency characteristic of hollow/vascular dark circles.

3. Should the treated area be massaged after JUVELOOK injections?

No. Thanks to the size and even distribution of the fine PDLA microparticles, the risk of nodule formation is extremely low. Therefore, no vigorous massage is necessary after treatment, which increases patient comfort and simplifies the post-injection protocol.

4. What is the recommended treatment protocol for JUVELOOK?

To achieve the maximum collagen biostimulation effect, a series of 2 to 3 sessions, spaced 4 to 6 weeks apart, is generally recommended. The exact number of sessions depends on the initial skin condition and the patient's specific goals, particularly for dark circle correction.

5. How long do the results obtained with JUVELOOK last?

The results of JUVELOOK, primarily based on the stimulation of endogenous collagen, are remarkably long-lasting. The rejuvenating and texture-improving effect can persist for 18 to 24 months after the initial protocol is completed. Periodic booster sessions can help maintain collagen production.